Back to BAILLIE GIFFORD & CO

RXRX
Showing 8 of 20 quarters

Position history for BAILLIE GIFFORD & CO's holdings in RECURSION PHARMACEUTICALS IN

BAILLIE GIFFORD & CO holds 23.7M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $72.7M as of 2026-Q1. The position was decreased (-0.4% shares). RXRX represents 0.1% of BAILLIE GIFFORD & CO's portfolio.

Current Value

$72.7M

Current Shares

23.7M

Total Value Change

-$126.7M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
23.7M
-0.4%
$72.7M0.1%$3.54
0
2025-Q4
Decreased
23.8M
-0.8%
$97.2M0.1%$4.11
0
2025-Q3
Decreased
24M
-0.8%
$117M0.1%$4.91
0
2025-Q2
Decreased
24.2M
-0.9%
$122.3M0.1%$5.03
0
2025-Q1
Decreased
24.4M
-1.9%
$129M0.1%$5.81
0
2024-Q4
Decreased
24.9M
-1.5%
$168.1M0.1%$6.77
0
2024-Q3
Decreased
25.2M
-5.1%
$166.3M0.1%$6.98
0
2024-Q2
Increased
26.6M
+10.5%
$199.4M0.2%$7.50
40

Other major holders of RXRX: ARK Investment Management LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used